Beacon Rise Holdings - Statement re. Suspension
The information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the
Beacon Rise Holdings Plc
("Beacon Rise" or the "Company")
Proposed acquisition of Ergotec Health LLP
Potential further acquisitions
and
Suspension of Listing and Share Trading
Beacon Rise (LSE: BRS) is pleased to announce that it has entered non-binding heads of terms save for exclusivity and other customary terms in relation to the proposed acquisition of Ergotec Health LLP ("Ergotec Health") by the Company for a consideration of approximately
The Proposed Ergotec Acquisition remains subject to a number of factors, including but not limited to, the completion of due diligence to the satisfaction of both parties, regulatory and shareholder approval, as well as the negotiation and entry into a final binding acquisition agreement (the "Acquisition Agreement"). Accordingly, there can be no certainty that an Acquisition Agreement will be entered into or that the Proposed Ergotec Acquisition will complete, nor or on the terms outlined in this announcement.
Following the satisfactory completion of due diligence by both parties, execution of the Acquisition Agreement and subject to the Acquisition Agreement becoming unconditional, the Company intends to seek to cancel its ordinary shares of
Allenby Capital Limited ("Allenby Capital") has been appointed to act as Beacon Rise' Sponsor in connection with the Proposed Ergotec Acquisition and has been engaged to act as the Company's Nominated Adviser in connection with Admission.
Potential further acquisitions
In addition to the Proposed Ergotec Acquisition, the Company announces that it is in preliminary discussions to potentially acquire a
At this stage heads of terms, including key terms such as the consideration payable, for the Potential Further Acquisitions have not yet been agreed. In addition, discussions in relation to the Potential Further Acquisitions remain at an early stage and will therefore be subject to a number of factors, including but not limited to, the completion of due diligence to the satisfaction of all parties, negotiation of transaction terms, regulatory and shareholder approval, as well as the negotiation and entry into final binding acquisition agreements. As such, there is no certainty that the Potential Further Acquisitions will proceed nor any certainty regarding the terms on which they would proceed.
The Company will release further announcements in respect of the Company's discussions concerning the Proposed Training-provider Acquisition and the Proposed Chiropractor Acquisition as and when appropriate.
The Proposed Ergotec Acquisition, the Proposed Training-provider Acquisition and the Proposed Chiropractor Acquisition (together the "Proposed Acquisitions") are each separate and not inter-conditional. Accordingly, each of the aforementioned proposed acquisitions will not be impacted by either failing to complete for any reason. However, in the event that one fails to complete, the Company intends to identify a replacement acquisition target.
It is currently envisaged that the Company will seek to simultaneously enter into final binding acquisition agreements in respect of the Proposed Acquisitions prior to Cancellation and Admission. However, the Company intends to proceed with Cancellation and Admission should a final binding acquisition agreement be agreed in relation to at least one of the aforementioned proposed acquisitions.
Information about Ergotec Health
Ergotec Health, registered in
Operating from its strategically located premises in
The business is embedded within the local community which provides a long-standing and loyal client base, engaging private clients directly, with long-term users engaging the clinic for up to 20 years. Ergotec Health also delivers treatments to third-party referrals as a recognised provider by all major Private Medical Insurers ("PMIs").
Ergotec Health's unaudited accounts for the year ended 31 March 2025 states that Ergotec Health generated revenues in the financial year of approximately
"Entry into the non-binding heads of terms in relation to the Proposed Ergotec Acquisition marks an important early milestone in the execution of the Company's buy-and-build strategy, underscoring the Company's long-term commitment to creating sustainable value for shareholders. The Company's strategic priorities will continue to focus on the training of healthcare professionals as well as the delivery of high-quality medical services.
In addition, the proposed admission of the enlarged share capital to trading on AIM is expected to further strengthen the Company's platform for future growth and provide greater flexibility in achieving its strategic objectives. The Company will continue to provide timely updates to the market on subsequent developments."
Temporary suspension of listing and trading of Ordinary Shares
Each of the proposed acquisitions outlined above are respectively classified as an "initial transaction" under
Should final terms for any of the proposed acquisitions outlined above be agreed, the Company will issue an announcement with further details pursuant to UKLR 13.4.22R and UKLR 13.4.23R.
The parties intend to proceed as quickly as possible with the Proposed Acquisitions. However, there can be no certainty that the Proposed Acquisitions will successfully complete, nor as to the final terms or timing of the Proposed Acquisitions. If the Proposed Acquisitions do not complete for any reason, it is expected that the suspension of the Company's listing on the Official List will be lifted, subject to FCA approval, and trading in the Company's shares on the Main Market of the London Stock Exchange will recommence.
Enquiries:
|
Beacon Rise Holdings Plc |
|
|
|
|
|
Allenby Capital Limited - Sponsor and Financial Adviser |
Tel: +44 (0)20 3328 5656 |
|
|
|
|
LDC Nominee Secretary Limited - Company Secretary
|
|
|
Legal Entity Identifier (LEI) |
2138007PIYMZMBWD4M27 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE